120 related articles for article (PubMed ID: 1538283)
21. A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab')2 fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation.
Nachbaur D; Herold M; Eibl B; Glassl H; Schwaighofer H; Huber C; Gächter A; Pichl M; Niederwieser D
Immunology; 1997 Feb; 90(2):212-8. PubMed ID: 9135549
[TBL] [Abstract][Full Text] [Related]
22. The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
Ogata S; Bando Y; Kimura S; Ando H; Nakahata Y; Ogihara Y; Kaneko T; Minoura K; Kaida M; Yokota Y; Furukawa S; Ishii M
J Cardiol; 2009 Feb; 53(1):15-9. PubMed ID: 19167633
[TBL] [Abstract][Full Text] [Related]
23. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
[TBL] [Abstract][Full Text] [Related]
24. Role of Natural Killer Cells in Intravenous Immunoglobulin-Induced Graft-versus-Host Disease Inhibition in NOD/LtSz-scidIL2rg(-/-) (NSG) Mice.
Gregoire-Gauthier J; Fontaine F; Benchimol L; Nicoletti S; Selleri S; Dieng MM; Haddad E
Biol Blood Marrow Transplant; 2015 May; 21(5):821-8. PubMed ID: 25596424
[TBL] [Abstract][Full Text] [Related]
25. Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease.
Wakiguchi H; Hasegawa S; Suzuki Y; Kudo K; Ichiyama T
Pediatr Res; 2015 Apr; 77(4):536-40. PubMed ID: 25580740
[TBL] [Abstract][Full Text] [Related]
26. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
Chang LS; Lo MH; Li SC; Yang MY; Hsieh KS; Kuo HC
Oncotarget; 2017 Jan; 8(2):2044-2052. PubMed ID: 27893416
[TBL] [Abstract][Full Text] [Related]
27. Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL).
Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Afkham A; Danaii S; Abdollahi-Fard S; Heidari L; Jadidi-Niaragh F; Younesi V; Nouri M; Yousefi M
Biomed Pharmacother; 2017 Aug; 92():1095-1102. PubMed ID: 28622710
[TBL] [Abstract][Full Text] [Related]
28. Intravenous immune globulin for prevention of bacterial infections in pediatric AIDS patients.
Crow ME
Am J Health Syst Pharm; 1995 Apr; 52(8):803-11. PubMed ID: 7634115
[TBL] [Abstract][Full Text] [Related]
29. Exposure of NK cells to intravenous immunoglobulin induces IFN gamma release and degranulation but inhibits their cytotoxic activity.
Jacobi C; Claus M; Wildemann B; Wingert S; Korporal M; Römisch J; Meuer S; Watzl C; Giese T
Clin Immunol; 2009 Dec; 133(3):393-401. PubMed ID: 19828380
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
[TBL] [Abstract][Full Text] [Related]
31. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
[TBL] [Abstract][Full Text] [Related]
32. A randomized prospective study on the use of 2 g-IVIG or 1 g-IVIG as therapy for Kawasaki disease.
Sakata K; Hamaoka K; Ozawa S; Niboshi A; Yoshihara T; Nishiki T; Nakagawa Y; Kazuta K; Morimoto Y; Kamiya Y; Yamamoto T; Horii Y; Kido S
Eur J Pediatr; 2007 Jun; 166(6):565-71. PubMed ID: 17103193
[TBL] [Abstract][Full Text] [Related]
33. A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate.
Lee MS; An SY; Jang GC; Kim DS
Yonsei Med J; 2002 Aug; 43(4):527-32. PubMed ID: 12205742
[TBL] [Abstract][Full Text] [Related]
34. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.
Guo MM; Tseng WN; Ko CH; Pan HM; Hsieh KS; Kuo HC
Allergy; 2015 Mar; 70(3):310-8. PubMed ID: 25585854
[TBL] [Abstract][Full Text] [Related]
35. Intravenous immune globulin plus corticosteroids in refractory Kawasaki disease.
Jibiki T; Kato I; Shiohama T; Abe K; Anzai S; Takeda N; Yamaguchi KI; Kanazawa M; Kurosaki T
Pediatr Int; 2011 Oct; 53(5):729-735. PubMed ID: 21342358
[TBL] [Abstract][Full Text] [Related]
36. Functional differences between antiviral activities of sulfonated and intact intravenous immunoglobulin preparations toward varicella-zoster virus and cytomegalovirus.
Yajima M; Shiraki A; Daikoku T; Oyama Y; Yoshida Y; Shiraki K
J Infect Chemother; 2015 Jun; 21(6):427-33. PubMed ID: 25824903
[TBL] [Abstract][Full Text] [Related]
37. A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease.
Wei M; Huang M; Chen S; Huang G; Huang M; Qiu D; Guo Z; Jiang J; Zhou X; Yu Q; Guo Y; Fu L; Gao W; Li F
Pediatr Cardiol; 2015 Aug; 36(6):1166-72. PubMed ID: 25812827
[TBL] [Abstract][Full Text] [Related]
38. Increased pregnancy rates after IVF/ET with intravenous immunoglobulin treatment in women with elevated circulating C56+ cells.
Coulam CB; Goodman C
Early Pregnancy (Cherry Hill); 2000 Apr; 4(2):90-8. PubMed ID: 11723539
[TBL] [Abstract][Full Text] [Related]
39. Effect of intravenous immunoglobulin on inhibiting peripheral blood lymphocyte apoptosis in acute Kawasaki disease.
Yi QJ; Li CR; Yang XQ
Acta Paediatr; 2001 Jun; 90(6):623-7. PubMed ID: 11440093
[TBL] [Abstract][Full Text] [Related]
40. Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia.
Aspalter RM; Sewell WA; Dolman K; Farrant J; Webster AD
Clin Exp Immunol; 2000 Sep; 121(3):506-14. PubMed ID: 10971518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
